Viewing Study NCT04847895


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-01-27 @ 10:35 AM
Study NCT ID: NCT04847895
Status: COMPLETED
Last Update Posted: 2021-04-19
First Post: 2021-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular (Wet) Age-related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lucentis View
None Ranibizumab View
None Neovascular (wet) age-related macular degeneration View
None nAMD View
None diabetic macular edema View
None retinal vein occlusions View
None choroidal neovascularizations View